Is Intellia Therapeutics, Inc. (NTLA) a Buy, Sell, or Hold?
Intellia Therapeutics, Inc.
NASDAQ:NTLA
$13.04 USD
-$0.26 (-1.95%)
- Volume
- 3.92M
- Average Volume
- 6.91M
- Market Capitalization
- $1.46B
- P/E Ratio
- -3.68
- Dividend Yield
- 0.00%
- Price Target
- $25.00
- Year High
- $28.25
- Year Low
- $7.95
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.10
NTLA vs. The Competition
| Properties | NTLA | BCRX | BHVN | IMNM |
|---|---|---|---|---|
| Market Cap | $1.46B | $1.98B | $1.57B | $2.19B |
| Shares Outstanding | $112.21M | $209.89M | $105.87M | $95.6M |
| P/E Ratio | -3.68 | -5.44 | -2.62 | -9.59 |
| EPS | -3.33 | -1.89 | -4.39 | -1.99 |
| Day Low | 12.88 | 9.17 | 14.56 | 21.92 |
| Day high | 13.38 | 9.91 | 14.985 | 22.975 |
| Year Low | 7.95 | 6 | 7.48 | 8.477 |
| Year High | 28.25 | 11.22 | 18.566 | 27.65 |
| Average Price 50 | 14.2875 | 9.1722 | 12.041 | 21.1092 |
| Average Price 200 | 13.6791 | 8.1002 | 11.64275 | 20.31333 |
| Volume | 3.92M | 6.68M | 1.27M | 1.09M |
| Average Volume | - | - | - | - |